This past weekend’s Washington Post had an article about the Food and Drug Administration’s (FDA) regulation of smartphone apps that serve medical-related purposes. Much of this piece is specific to health issues, but the dynamics it illustrates could offer a few lessons and insights into how government and private developers could interact regarding 3rd party apps for alerts and warnings. Continue reading »

